Retained risk is increasingly becoming another. For larger, well-managed organizations, self-insured retentions (SIRs) can serve as a powerful strategic lever, improving cost control and supporting long-term program stability
Proposed federal legislation would allow Medicare to cover GLP1 drugs for obesity and related comorbidities beginning as early as mid-2026, subject to enactment and regulatory implementation
Current Pharmaceutical Design (2011) 6
I know our first inclination is often to panic call every doctor we know and google until the cows come home
By promoting fat reduction and improving insulin sensitivity, L-Carnitine Weight Loss Drops not only helps with weight management but also lowers the risk of complications associated with diabetes, making it a powerful, non-invasive ally in metabolic health and diabetic care
doi: 10.1212/WNL.0000000000001608